ArticleEcancermedicalscience2022

Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2.

Dana Narváez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.